CEBPA and metabolic dysfunction-associated steatotic liver disease: In a genetically engineered mouse model of maternal high-fat diet during pregnancy, disruption of the C/EBPα and histone acetyltransferase p300 interaction by substituting serine with alanine at residue 193 on C/EBPα prevents pups from developing NAFLD compared to wildtype mouse pups.